Cargando…
Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart
The current cardiovascular risk tables are based on a 10-year period and therefore, do not allow for predictions in the short or medium term. Thus, we are unable to take more aggressive therapeutic decisions when this risk is very high. To develop and validate a predictive model of cardiovascular di...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058961/ https://www.ncbi.nlm.nih.gov/pubmed/26632692 http://dx.doi.org/10.1097/MD.0000000000001980 |
_version_ | 1782459345642979328 |
---|---|
author | Artigao-Ródenas, Luis Miguel Carbayo-Herencia, Julio Antonio Palazón-Bru, Antonio Divisón-Garrote, Juan Antonio Sanchis-Domènech, Carlos Vigo-Aguiar, Isabel Gil-Guillén, Vicente Francisco |
author_facet | Artigao-Ródenas, Luis Miguel Carbayo-Herencia, Julio Antonio Palazón-Bru, Antonio Divisón-Garrote, Juan Antonio Sanchis-Domènech, Carlos Vigo-Aguiar, Isabel Gil-Guillén, Vicente Francisco |
author_sort | Artigao-Ródenas, Luis Miguel |
collection | PubMed |
description | The current cardiovascular risk tables are based on a 10-year period and therefore, do not allow for predictions in the short or medium term. Thus, we are unable to take more aggressive therapeutic decisions when this risk is very high. To develop and validate a predictive model of cardiovascular disease (CVD), to enable calculation of risk in the short, medium and long term in the general population. Cohort study with 14 years of follow-up (1992–2006) was obtained through random sampling of 342,667 inhabitants in a Spanish region. Main outcome: time-to-CVD. The sample was randomly divided into 2 parts [823 (80%), construction; 227 (20%), validation]. A stepwise Cox model was constructed to determine which variables at baseline (age, sex, blood pressure, etc) were associated with CVD. The model was adapted to a points system and risk groups based on epidemiological criteria (sensitivity and specificity) were established. The risk associated with each score was calculated every 2 years up to a maximum of 14. The estimated model was validated by calculating the C-statistic and comparison between observed and expected events. In the construction sample, 76 patients experienced a CVD during the follow-up (82 cases per 10,000 person-years). Factors in the model included sex, diabetes, left ventricular hypertrophy, occupational physical activity, age, systolic blood pressure × heart rate, number of cigarettes, and total cholesterol. Validation yielded a C-statistic of 0.886 and the comparison between expected and observed events was not significant (P: 0.49–0.75). We constructed and validated a scoring system able to determine, with a very high discriminating power, which patients will develop a CVD in the short, medium, and long term (maximum 14 years). Validation studies are needed for the model constructed. |
format | Online Article Text |
id | pubmed-5058961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-50589612016-11-01 Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart Artigao-Ródenas, Luis Miguel Carbayo-Herencia, Julio Antonio Palazón-Bru, Antonio Divisón-Garrote, Juan Antonio Sanchis-Domènech, Carlos Vigo-Aguiar, Isabel Gil-Guillén, Vicente Francisco Medicine (Baltimore) 3400 The current cardiovascular risk tables are based on a 10-year period and therefore, do not allow for predictions in the short or medium term. Thus, we are unable to take more aggressive therapeutic decisions when this risk is very high. To develop and validate a predictive model of cardiovascular disease (CVD), to enable calculation of risk in the short, medium and long term in the general population. Cohort study with 14 years of follow-up (1992–2006) was obtained through random sampling of 342,667 inhabitants in a Spanish region. Main outcome: time-to-CVD. The sample was randomly divided into 2 parts [823 (80%), construction; 227 (20%), validation]. A stepwise Cox model was constructed to determine which variables at baseline (age, sex, blood pressure, etc) were associated with CVD. The model was adapted to a points system and risk groups based on epidemiological criteria (sensitivity and specificity) were established. The risk associated with each score was calculated every 2 years up to a maximum of 14. The estimated model was validated by calculating the C-statistic and comparison between observed and expected events. In the construction sample, 76 patients experienced a CVD during the follow-up (82 cases per 10,000 person-years). Factors in the model included sex, diabetes, left ventricular hypertrophy, occupational physical activity, age, systolic blood pressure × heart rate, number of cigarettes, and total cholesterol. Validation yielded a C-statistic of 0.886 and the comparison between expected and observed events was not significant (P: 0.49–0.75). We constructed and validated a scoring system able to determine, with a very high discriminating power, which patients will develop a CVD in the short, medium, and long term (maximum 14 years). Validation studies are needed for the model constructed. Wolters Kluwer Health 2015-10-30 /pmc/articles/PMC5058961/ /pubmed/26632692 http://dx.doi.org/10.1097/MD.0000000000001980 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 3400 Artigao-Ródenas, Luis Miguel Carbayo-Herencia, Julio Antonio Palazón-Bru, Antonio Divisón-Garrote, Juan Antonio Sanchis-Domènech, Carlos Vigo-Aguiar, Isabel Gil-Guillén, Vicente Francisco Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart |
title | Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart |
title_full | Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart |
title_fullStr | Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart |
title_full_unstemmed | Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart |
title_short | Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart |
title_sort | construction and validation of a 14-year cardiovascular risk score for use in the general population: the puras-geva chart |
topic | 3400 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058961/ https://www.ncbi.nlm.nih.gov/pubmed/26632692 http://dx.doi.org/10.1097/MD.0000000000001980 |
work_keys_str_mv | AT artigaorodenasluismiguel constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart AT carbayoherenciajulioantonio constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart AT palazonbruantonio constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart AT divisongarrotejuanantonio constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart AT sanchisdomenechcarlos constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart AT vigoaguiarisabel constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart AT gilguillenvicentefrancisco constructionandvalidationofa14yearcardiovascularriskscoreforuseinthegeneralpopulationthepurasgevachart |